← Browse by Condition
Medical Condition
drug induced liver injury
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for drug induced liver injury sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT05060289
Recruiting
A Prognostic Model for Drug-induced Liver Injury in China
Enrollment
3,000 pts
Location
China
Sponsor
Beijing Friendship Hospital
NCT06922669
Recruiting
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
Enrollment
232 pts
Location
China
Sponsor
General Hospital of Shenyang M...
NCT04964310
Recruiting
Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
Enrollment
339 pts
Location
China
Sponsor
The First Affiliated Hospital ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology